Your browser doesn't support javascript.
loading
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.
Godman, Brian; Bucsics, Anna; Vella Bonanno, Patricia; Oortwijn, Wija; Rothe, Celia C; Ferrario, Alessandra; Bosselli, Simone; Hill, Andrew; Martin, Antony P; Simoens, Steven; Kurdi, Amanj; Gad, Mohamed; Gulbinovic, Jolanta; Timoney, Angela; Bochenek, Tomasz; Salem, Ahmed; Hoxha, Iris; Sauermann, Robert; Massele, Amos; Guerra, Augusto Alfonso; Petrova, Guenka; Mitkova, Zornitsa; Achniotou, Gnosia; Laius, Ott; Sermet, Catherine; Selke, Gisbert; Kourafalos, Vasileios; Yfantopoulos, John; Magnusson, Einar; Joppi, Roberta; Oluka, Margaret; Kwon, Hye-Young; Jakupi, Arianit; Kalemeera, Francis; Fadare, Joseph O; Melien, Oyvind; Pomorski, Maciej; Wladysiuk, Magdalene; Markovic-Pekovic, Vanda; Mardare, Ileana; Meshkov, Dmitry; Novakovic, Tanja; Fürst, Jurij; Tomek, Dominik; Zara, Corrine; Diogene, Eduardo; Meyer, Johanna C; Malmström, Rickard; Wettermark, Björn; Matsebula, Zinhle.
Afiliação
  • Godman B; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
  • Bucsics A; Health Economics Centre, University of Liverpool Management School, Liverpool, United Kingdom.
  • Vella Bonanno P; Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Oortwijn W; School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
  • Rothe CC; Mechanism of Coordinated Access to Orphan Medicinal Products (MoCA), Brussels, Belgium.
  • Ferrario A; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
  • Bosselli S; Ecorys, Rotterdam, Netherlands.
  • Hill A; Department for Health Evidence, Radboud University Medical Center, Nijmegen, Netherlands.
  • Martin AP; Department of Drug Management, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.
  • Simoens S; Division of Health Policy and Insurance Research, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, United States.
  • Kurdi A; EURORDIS-Rare Diseases Europe, Paris, France.
  • Gad M; Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Gulbinovic J; Health Economics Centre, University of Liverpool Management School, Liverpool, United Kingdom.
  • Timoney A; HCD Economics, The Innovation Centre, Daresbury, United Kingdom.
  • Bochenek T; KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium.
  • Salem A; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
  • Hoxha I; Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq.
  • Sauermann R; Global Health and Development Group, Imperial College, London, United Kingdom.
  • Massele A; Department of Pathology, Forensic Medicine and Pharmacology, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Vilnius, Lithuania.
  • Guerra AA; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
  • Petrova G; NHS Lothian, Edinburgh, United Kingdom.
  • Mitkova Z; Department of Drug Management, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.
  • Achniotou G; IQVIA, Brussels, Belgium.
  • Laius O; Department of Pharmacy, Faculty of Medicine, University of Medicine, Tirana, Albania.
  • Sermet C; Hauptverband der Österreichischen Sozialversicherungsträger, Vienna, Austria.
  • Selke G; Department of Biomedical Sciences, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
  • Kourafalos V; Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, Av. Presidente Antônio Carlos, Belo Horizonte, Brazil.
  • Yfantopoulos J; SUS Collaborating Centre - Technology Assessment & Excellence in Health (CCATES/UFMG), College of Pharmacy, Federal University of Minas Gerais. Av. Presidente Antônio Carlos, Belo Horizonte, Brazil.
  • Magnusson E; Department of Social Pharmacy and Pharmacoeconomics, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Joppi R; Department of Social Pharmacy and Pharmacoeconomics, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Oluka M; Health Insurance Organisation (HIO), Nicosia, Cyprus.
  • Kwon HY; State Agency of Medicines, Tartu, Estonia.
  • Jakupi A; IRDES, Paris, France.
  • Kalemeera F; Wissenschaftliches Institut der AOK (WIdO), Berlin, Germany.
  • Fadare JO; EOPYY-National Organization for the Provision of Healthcare Services, Athens, Greece.
  • Melien O; School of Economics and Political Science, University of Athens, Athens, Greece.
  • Pomorski M; Department of Health Services, Ministry of Health, Reykjavík, Iceland.
  • Wladysiuk M; Pharmaceutical Drug Department, Azienda Sanitaria Locale of Verona, Verona, Italy.
  • Markovic-Pekovic V; Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, Nairobi, Kenya.
  • Mardare I; Division of Biology and Public Health, Mokwon University, Daejeon, South Korea.
  • Meshkov D; UBT - Higher Education Institute, Prishtina, Kosovo.
  • Novakovic T; Department of Pharmacology and Therapeutics, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia.
  • Fürst J; Department of Pharmacology and Therapeutics, Ekiti State University, Ado-Ekiti, Nigeria.
  • Tomek D; Norwegian Institute of Public Health, Oslo, Norway.
  • Zara C; Agency for Health Technology Assessment and Tariff System (AOTMiT), Warsaw, Poland.
  • Diogene E; HTA Consulting, Cracow, Poland.
  • Meyer JC; Ministry of Health and Social Welfare, Banja Luka, Bosnia and Herzegovina.
  • Malmström R; Department of Social Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
  • Wettermark B; Public Health and Management Department, Faculty of Medicine, "Carol Davila", University of Medicine and Pharmacy Bucharest, Bucharest, Romania.
  • Matsebula Z; National Research Institution for Public Health, Moscow, Russia.
Front Public Health ; 6: 328, 2018.
Article em En | MEDLINE | ID: mdl-30568938
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Front Public Health Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Front Public Health Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido